Prof. BÜLENT AKDOĞAN

Publication Network

Articles 80

1. The effect of neoadjuvant chemotherapy on survival outcomes in patients with variant histologies who underwent radical cystectomy with precystectomy diagnostic accuracy: A multicenter study of the Turkish Urooncology Association

AKPINAR Ç., SÜER E., AKDOĞAN B., Izol V., Celik S., ASLAN G., et al.

INTERNATIONAL JOURNAL OF UROLOGY , 2025 (SCI-Expanded)

2. Lessons For COVID-19 Era: Impact of Delays in Surgery on Biochemical Recurrence-Free Survival and Adverse Oncological Outcomes in Patients with Prostate Cancer

ŞAHİN B., BOZKURT O., Sozen S., Ozen H., AKDOĞAN B., ASLAN G., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.23, no.2, pp.43-49, 2024 (ESCI)

3. Long-term follow-up results of multiparametric prostate MRI and the prognostic value of PI-RADS: a single-center retrospective cohort study

ÖNDER Ö., Ayva M., YARAŞIR Y., GÜRLER V., YAZICI M. S., AKDOĞAN B., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , vol.30, no.3, pp.139-151, 2024 (SCI-Expanded) Sustainable Development

4. Do Subgroup Evaluations Provide Additional Contributions to Biochemical Recurrence in Grade Group 4 and 5 Patients? A Multicenter Study by the Turkish Urooncology Association Prostate Cancer Working Group

Cetin T., Celik S., SÜER E., Sozen S., Izol V., AKDOĞAN B., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.23, no.1, pp.10-15, 2024 (ESCI) Sustainable Development

5. The Effect of Perineural Invasion on Biochemical Recurrence-free Survival Following Nerve-sparing Radical Prostatectomy

Kumsar S., ASLAN G., Suer E., AKDOĞAN B., Sozen S., Gülşen M., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.23, no.1, pp.1-5, 2024 (ESCI) Sustainable Development

6. Testicular metastasis in prostate cancer: A rare case of testicular metastasis diagnosed with Ga-68-PSMA and review of the literature

ÖZYİĞİT G., AKDOĞAN B., YILMAZ M. T., GÜNER G., BOZKURT M. F.

JOURNAL OF CLINICAL UROLOGY , vol.17, no.1, pp.79-82, 2024 (ESCI) Sustainable Development

7. Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient Cohort

Cetin T., Celik S., Sozen S., Ozen H., AKDOĞAN B., ASLAN G., et al.

UROLOGY JOURNAL , vol.21, no.5, pp.320-324, 2024 (SCI-Expanded)

8. What is the Optimal Time Period for Postponing Nephrectomy in Patients with Renal Cell Carcinoma of Various Stages?

Celik S., Tinay I., Sozen S., Ozen H., AKDOĞAN B., Aslan G., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.22, no.4, pp.150-155, 2023 (ESCI) Sustainable Development

9. Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study

KIZILAY F., Celik S., Narter F., Sozen S., Ozen H., AKDOĞAN B., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.22, no.3, pp.100-105, 2023 (ESCI) Sustainable Development

10. Treatment Options in Low-risk Prostate Cancer Patients: A Retrospective Database Report

ERBATU O., MÜEZZİNOĞLU T., AKDOĞAN B., ASLAN G., SÖZEN S., BALTACI S., et al.

Üroonkoloji Bülteni , vol.22, no.2, pp.72-75, 2023 (Peer-Reviewed Journal)

11. Oncological outcomes of papillary versus clear cell renal cell carcinoma in pT1 and pT2 stage: Results from a contemporary Turkish patient cohort

Cetin T., Celik S., Sozen S., AKDOĞAN B., İZOL V., ASLAN G., et al.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica , vol.95, no.2, pp.11218, 2023 (ESCI)

12. Endovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?

Ahmadov J., ÇAY F., Eldem G., AKDOĞAN B., BİLEN C. Y., AKI F. T., et al.

Diagnostic and Interventional Radiology , vol.28, no.6, pp.597-602, 2022 (SCI-Expanded)

13. Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association

İZOL V., Ok F., ASLAN G., AKDOĞAN B., Sozen S., ÖZDEN E., et al.

PROSTATE , vol.82, no.7, pp.763-771, 2022 (SCI-Expanded) Sustainable Development

14. Impact of Trifecta definition on rates and predictors of "successful" robotic partial nephrectomy for localized renal masses: results from the Surface-Intermediate-Base Margin Score International Consortium

Campi R., Grosso A. A., Lane B. R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

MINERVA UROLOGY AND NEPHROLOGY , vol.74, no.2, pp.186-193, 2022 (SCI-Expanded)

15. Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium)

Di Maida F., Campi R., Lane B. R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

JOURNAL OF CLINICAL MEDICINE , vol.11, no.7, 2022 (SCI-Expanded)

16. Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses

Campi R., Di Maida F., Lane B. R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

EJSO , vol.48, no.3, 2022 (SCI-Expanded)

17. Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association

KOPARAL M. Y., SÖZEN T. S., Karşıyakalı N., ASLAN G., AKDOĞAN B., ŞAHİN B., et al.

Prostate , vol.82, no.4, pp.425-432, 2022 (SCI-Expanded) Sustainable Development

18. Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey

Celik S., KIZILAY F., YÖRÜKOĞLU K., ASLAN G., Ozen H., AKDOĞAN B., et al.

UROLOGIA INTERNATIONALIS , vol.106, no.1, pp.35-43, 2022 (SCI-Expanded) Sustainable Development

19. Impact of Variant Histology on Clinical and Pathological Outcomes in Patients with the Upper Urinary Tract Urothelial Carcinoma

Artykov M., HABERAL H. B., ALTAN M., KÖSEMEHMETOĞLU K., YAZICI M. S., Ozen H., et al.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , vol.56, no.2, pp.284-290, 2022 (ESCI)

20. Non-choriocarcinomatous trophoblastic tumors of testis in postchemotherapy retroperitoneal lymph node dissections

Ertoy Baydar D., Katıpoglu K., ALTAN M., AKDOĞAN B.

Virchows Archiv , vol.482, 2022 (SCI-Expanded)

21. Adjuvant Treatment Approaches after Radical Prostatectomy with Lymph Node Involvement

Tavukçu H. H., Erbatu O., AKDOĞAN B., İZOL V., Yücetaş U., Sözen S., et al.

Asian Pacific Journal of Cancer Prevention , vol.23, no.7, pp.2279-2284, 2022 (Scopus)

22. How accurate is radiological imaging for perirenal fat and renal vein invasion in renal cell carcinoma?

ÜÇER O., MÜEZZİNOĞLU T., ÖZDEN E., ASLAN G., İZOL V., BAYAZIT Y., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.9, 2021 (SCI-Expanded)

23. The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

İZOL V., AKDOĞAN N., Ozen H., AKDOĞAN B., Kural A. R., Tuna M. B., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021 (SCI-Expanded) Sustainable Development

24. The SPARE score reliably predicts the conversion from open partial to radical nephrectomy

HABERAL H. B., ÇITAMAK B., ALTAN M., YAZICI M. S., AKDOĞAN B., Ozen H., et al.

CROATIAN MEDICAL JOURNAL , vol.62, no.4, pp.464-471, 2021 (SCI-Expanded)

25. Comparison of diagnostic performances of urine cytology before and after the use of the paris system criteria: An institutional experience from Turkey

Onder S., KURTULAN O., KAVUNCUOĞLU A., AKDOĞAN B.

JOURNAL OF CYTOLOGY , vol.38, no.3, pp.133-139, 2021 (SCI-Expanded)

26. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?

HÜRMÜZ P., ÖZYİĞİT G., Kilickap S., BEDÜK ESEN Ç. S., AKDOĞAN B., Ozen H., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.39, no.6, 2021 (SCI-Expanded)

27. Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey

Celik S., KIZILAY F., YÖRÜKOĞLU K., Ozen H., AKDOĞAN B., İZOL V., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.20, no.1, pp.19-25, 2021 (ESCI)

28. Prognostic Significance of Surgical Margin Status and Gleason Grade at the Positive Surgical Margin in Predicting Biochemical Recurrence After Radical Prostatectomy in a Turkish Patient Cohort

Koparal M. Y., SÖZEN T. S., ASLAN G., BALTACI S., SÜER E., MÜEZZİNOĞLU T., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.20, no.1, pp.26-39, 2021 (ESCI)

29. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.

ASLAN G., Celik S., Sozen S., AKDOĞAN B., İZOL V., BİLEN C. Y., et al.

International journal of clinical practice , vol.75, 2021 (SCI-Expanded)

30. Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors

ALTAN M., HABERAL H. B., AŞCI A., GÜDELOĞLU A., DOĞRUL A. B., YAZICI M. S., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1, pp.186-191, 2021 (SCI-Expanded)

31. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience

ÖZYİĞİT G., HÜRMÜZ P., AKINCI D., Esen S. C. B., YILMAZ M., AKDOĞAN B., et al.

CANCER RADIOTHERAPIE , vol.24, no.8, pp.805-811, 2020 (SCI-Expanded) Sustainable Development

32. Prostatitis, the Great Mimicker of Prostate Cancer: Can We Differentiate Them Quantitatively With Multiparametric MRI?

Uysal A., Karaosmanoglu A. D., KARÇAALTINCABA M., AKATA D., AKDOĞAN B., Baydar D. E., et al.

AMERICAN JOURNAL OF ROENTGENOLOGY , vol.215, no.5, pp.1104-1112, 2020 (SCI-Expanded) Sustainable Development

33. Primary ependymoma of the retropubic space in a male patient

Kapakli E. T., KÖSEMEHMETOĞLU K., KAYMAZ F. F., AKDOĞAN B., Ozmen M., Baydar D. E.

ULTRASTRUCTURAL PATHOLOGY , vol.44, no.4-6, pp.505-510, 2020 (SCI-Expanded)

34. Assessing the Association of Surface-Intermediate-Base Margin Score with Perioperative Outcomes and Parenchymal Volume Preserved during Partial Nephrectomy

ÇITAMAK B., HABERAL H. B., AKDOĞAN B.

UROLOGIA INTERNATIONALIS , vol.104, pp.781-788, 2020 (SCI-Expanded)

35. Factors Affecting Surgical Margin Positivity after Radical Prostatectomy in the Turkish Population: A Multicenter Study of the Urooncology Association

Celik S., ASLAN G., Sozen S., Ozen H., AKDOĞAN B., BALTACI S., et al.

UROLOGIA INTERNATIONALIS , vol.104, pp.724-730, 2020 (SCI-Expanded) Sustainable Development

36. Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination

ALTAN M., ÇITAMAK B., Mammadov E., KONAR N. M., AKDOĞAN B., Ozen H.

JOURNAL OF UROLOGICAL SURGERY , vol.7, no.2, pp.83-87, 2020 (ESCI)

37. Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study

Minervini A., Campi R., Lane B. R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

JOURNAL OF UROLOGY , vol.203, no.3, pp.496-503, 2020 (SCI-Expanded)

38. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi R., Brookman-May S. D., Subiela Henriquez J. D., AKDOĞAN B., Brausi M., Klatte T., et al.

EUROPEAN UROLOGY FOCUS , vol.5, no.6, pp.1029-1057, 2019 (SCI-Expanded)

39. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU)

Brookman-May S. D., Campi R., Henriquez J. D. S., Klatte T., Langenhuijsen J. F., Brausi M., et al.

EUROPEAN UROLOGY FOCUS , vol.5, no.5, pp.756-787, 2019 (SCI-Expanded) Sustainable Development

40. Two Cases of Bladder Adenocarcinoma After Augmentation Cystoplasty

Ceyhan E., Bozaci A. C., DOĞAN H. S., ERGEN A., AKDOĞAN B., KATİPOĞLU K., et al.

JOURNAL OF UROLOGICAL SURGERY , vol.6, no.1, pp.76-78, 2019 (ESCI)

41. Squamous cell carcinoma of the penis: a clinicopathological study from a population with late circumcision

Baydar D. E., Akkaya H., Apa D. D., Bal N., Demirsam A., Gucluer B., et al.

ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY , vol.60, no.2, pp.521-529, 2019 (SCI-Expanded) Sustainable Development

42. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?

Capitanio U., Stewart G. D., Klatte T., AKDOĞAN B., Roscigno M., Marszalek M., et al.

EUROPEAN UROLOGY FOCUS , vol.4, no.6, pp.972-977, 2018 (SCI-Expanded)

43. PATTERNS AND PREDICTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY FOR T1 RENAL MASSES: RESULTS OF A MULTI-CENTRE PROSPECTIVE COHORT STUDY FROM THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM (IDEAL PHASE 2B)

Campi R., Kutikov A., Lane B., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

ANTICANCER RESEARCH , vol.38, no.4, pp.2580-2583, 2018 (SCI-Expanded)

44. Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort

TİNAY İ., ASLAN G., Kural A. R., Ozen H., AKDOĞAN B., YILDIRIM A., et al.

UROLOGIA INTERNATIONALIS , vol.100, no.1, pp.43-49, 2018 (SCI-Expanded) Sustainable Development

45. An unusual localization of seven months delayed pelvic lymphocele following radical retropubic prostatectomy: Case report and literature review

HAZIR B., HABERAL H. B., AKINCI D., AKDOĞAN B.

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS , vol.44, pp.181-184, 2018 (ESCI)

46. A Rare Presentation of Germ Cell Neoplasia: Persistant Mullerian Duct Syndrome

BEKSAÇ A. T., DÖNMEZ M. İ., Aydin C., BAYDAR D., YAZICI M. S., ERGEN A., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.3, pp.101-104, 2017 (ESCI)

47. An Independent Validation of 2010 Tumor-Node-Metastasis Classification for Renal Cell Carcinoma: A Multi-center Study by the Urooncology Association of Turkey Renal Cancer-Study Group

Ozkan T. A., Eskicorapci S., YAYCIOĞLU Ö., AKDOĞAN B., Gogus C., Dirim A., et al.

JOURNAL OF UROLOGICAL SURGERY , vol.4, no.2, pp.53-60, 2017 (ESCI)

48. The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience

KARADAĞ Ö., Erden A., AYHAN E. A., BÖLEK E. Ç., KALYONCU U., ARMAĞAN B., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.47, no.5, pp.1307-1314, 2017 (SCI-Expanded)

49. RESECTION TECHNIQUES FOR NEPHRON SPARING SURGERY VARY: INSIGHTS FROM A PROSPECTIVELY COLLECTED MULTI-INSTITUTIONAL COHORT HARNESSING THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE (SIB INTERNATIONAL CONSORTIUM)

Minervini A., Campi R., Mari A., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., et al.

ANTICANCER RESEARCH , vol.36, no.5, pp.2603-2605, 2016 (SCI-Expanded)

50. PREDICTIVE FACTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY IN A COHORT OF "ENUCLEORESECTIVE" CENTERS: INSIGHTS FROM THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM

Minervini A., Campi R., Mari A., De Cobelli O., Sanguedolce F., Villeda-sandoval C., et al.

ANTICANCER RESEARCH , vol.36, no.5, pp.2602-2603, 2016 (SCI-Expanded)

51. Urethral Stricture is an Unpleasant Complication after Prostate Surgery: A Critical Review of Current Literature

SÖĞÜTDELEN E., HABERAL H. B., Guliyev F., AKDOĞAN B.

JOURNAL OF UROLOGICAL SURGERY , vol.3, no.1, pp.1-6, 2016 (ESCI)

52. Lymph Node Dissection and Adrenalectomy in Locally Advanced Renal Cell Carcinoma

ÇITAMAK B., SÖĞÜTDELEN E., AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.14, no.3, pp.207-209, 2015 (ESCI)

53. Postchemotherapy Retroperitoneal Lymph Node Dissection

ÇITAMAK B., AKDOĞAN B., ALTAN M., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.13, no.3, pp.169-175, 2014 (ESCI)

54. The effect of local anesthetic infiltration around nephrostomy tract on postoperative pain control after percutaneous nephrolithotomy

Tuzel E., Kiziltepe G., AKDOĞAN B.

UROLITHIASIS , vol.42, no.4, pp.353-358, 2014 (SCI-Expanded)

55. How Can One Define the Surgical Quality of Radical Cystectomy?

ALTAN M., ÖZDEMİR B., ÇITAMAK B., AKDOĞAN B., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.13, no.2, pp.70-74, 2014 (ESCI)

56. Most frequently seen side effects of targeted therapy: how to manage?

KARA Ö., AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.3, pp.179-185, 2013 (ESCI)

57. A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy

ASLAN G., BALTACI S., AKDOĞAN B., Kuyumcuoglu U., Kaplan M., Cal C., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.31, no.5, pp.664-670, 2013 (SCI-Expanded)

58. Role of carbonic anhydrase IX (CAIX) in patients with renal cell carcinoma: can we currently assess its definitive value in prognosis, prediction to treatment response and diagnosis, and as a therapeutic approach?

Brookman-May S., Marszalek M., Joniau S., Minervini A., Langenhujisen J. F., Ficarra V., et al.

BJU INTERNATIONAL , vol.111, no.7, pp.1015-1017, 2013 (SCI-Expanded)

59. New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate

AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.12, no.2, pp.111-114, 2013 (ESCI) Sustainable Development

60. Robot-assisted partial nephrectomy in patients with recurrent disease: fiction or fact?

Brookman-May S., Minervini A., Volpe A., Ficarra V., Salagierski M., Marszalek M., et al.

BJU INTERNATIONAL , vol.111, no.5, pp.692-694, 2013 (SCI-Expanded)

61. What Is the Contemporary Role of Radiofrequency Ablation in the Management of Small Renal Masses? Are Small Lesions the Radiologist's Tumors?

Salagierski M., AKDOĞAN B., Brookman-May S., Dobrowolska-Glazar B., Ficarra V., Langenhuijsen J. F., et al.

EUROPEAN UROLOGY , vol.63, no.3, pp.493-495, 2013 (SCI-Expanded)

62. Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?

GUNAY L. M., AKDOĞAN B., Koni A., INCI K., BİLEN C. Y., Ozen H.

CLINICAL GENITOURINARY CANCER , vol.11, no.1, pp.39-44, 2013 (SCI-Expanded)

63. Prospective Comparative Study of Two Protocols of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy

Tuzel E., AKTEPE O. C., AKDOĞAN B.

JOURNAL OF ENDOUROLOGY , vol.27, no.2, pp.172-176, 2013 (SCI-Expanded)

64. Primary Low Grade Intratesticular Leiomyosarcoma: Case Report and Review of the Literature

Abdullazade S., KARA Ö., AKDOĞAN B., Ertoy Baydar D.

TURKISH JOURNAL OF PATHOLOGY , vol.29, no.3, pp.227-230, 2013 (ESCI)

65. Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy

BOZACI A. C., AKDOĞAN B., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.11, no.2, pp.119-123, 2012 (ESCI) Sustainable Development

66. Prevalence and Predictors of Benign Lesions in Renal Masses Smaller Than 7 cm Presumed to be Renal Cell Carcinoma

AKDOĞAN B., GÜDELOĞLU A., INCI K., Gunay L. M., Koni A., Ozen H.

CLINICAL GENITOURINARY CANCER , vol.10, no.2, pp.121-125, 2012 (SCI-Expanded)

67. Malakoplakia of prostate as a complication of transrectal needle biopsy

GÜNER G., AKDOĞAN B., BAYDAR D.

CANADIAN JOURNAL OF UROLOGY , vol.19, no.1, pp.6124-6127, 2012 (SCI-Expanded)

68. Renal Cell Carcinoma with venous trombosis: Surgical management

Tombul S. T., AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.10, no.3, pp.32-35, 2011 (ESCI)

69. Algorithmic approach to rising PSA after curative prostate cancer treatment

Gunay L. M., Tombul S. T., AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.10, no.2, pp.51-55, 2011 (ESCI) Sustainable Development

70. Retroperitoneal Lymph Node Dissection for the Primary Treatment Recommendation in Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Contrary to European Guidelines

Gunay M., AKDOĞAN B., Uygur C., Ozen H.

EUROPEAN UROLOGY SUPPLEMENTS , vol.10, no.3, 2011 (SCI-Expanded)

71. Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLND

Inci K., DOĞAN H. S., AKDOĞAN B., BAYDAR D., ERGEN A., Ozen H.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.29, no.1, pp.38-42, 2011 (SCI-Expanded)

72. Renal cell carcinoma with inferior vena cava thrombus: The Hacettepe experience

Yazici S., Inci K., BİLEN C. Y., GÜDELOĞLU A., AKDOĞAN B., Ertoy D., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.28, no.6, pp.603-609, 2010 (SCI-Expanded)

73. Erectile dysfunction in successfully treated lymphoma patients

AKSOY S., HARPUTLUOĞLU H., KILIÇKAP S., DİNÇER M., DİZDAR Ö., AKDOĞAN B., et al.

SUPPORTIVE CARE IN CANCER , vol.16, no.3, pp.291-297, 2008 (SCI-Expanded)

74. Does age affect the prognosis of patients with testicular germ cell tumor?

Inci K., Dogan H. S., Akdogan B., Ergen A., Tasar C., Ozen H.

UROLOGIA INTERNATIONALIS , vol.79, no.2, pp.117-123, 2007 (SCI-Expanded)

75. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer

ERSOY O., ARAN R., AYDINLI M., SAYGILI YÖNEM N. Ö., HARMANCI Ö., AKDOĞAN B., et al.

INDIAN JOURNAL OF GASTROENTEROLOGY , vol.25, no.5, pp.258-259, 2006 (Scopus)

76. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma

Akdogan B., Dogan H. S., Eskicorapci S. Y., ŞAHİN A., Erkan I., Ozen H.

JOURNAL OF UROLOGY , vol.176, no.1, pp.48-52, 2006 (SCI-Expanded)

77. Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL

ESKICORAPCI S., Ozkara H. A., ONDER E., AKDOGAN B., ERKAN İ., CILIV G., et al.

CLINICAL BIOCHEMISTRY , vol.39, no.4, pp.363-366, 2006 (SCI-Expanded) Sustainable Development

78. Prostatic adenosquamous carcinoma metastasizing to testis

Baydar D. E., Kosemehmetoglu K., Akdogan B., Ozen H.

THESCIENTIFICWORLDJOURNAL , vol.6, pp.2491-2494, 2006 (SCI-Expanded)

79. Use of the holmium : YAG laser for ureterolithotripsy in children

Dogan H. S., Tekgul S., Akdogan B., Keskin M. S., Sahin A.

BJU INTERNATIONAL , vol.94, no.1, pp.131-133, 2004 (SCI-Expanded)

80. Antibiotic prophylaxis in percutaneous nephrolithotomy: Prospective study in 81 patients

Dogan H. S., Sahin A., Cetinkaya Y., Akdogan B., Ozden E., Kendi S.

JOURNAL OF ENDOUROLOGY , vol.16, no.9, pp.649-653, 2002 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 9

1. Telerehabilitation-Based versus Face-to-Face Pelvic Floor Muscle Training in Male Urinary Incontinence Following Radical Prostatectomy: A Randomized Clinical Trial

Atabey Gerlegiz E. N., Akbayrak T., Gürşen C., Mangır Bolat N., Gülören G., Çinar G. N., et al.

ICS 2024, Madrid, Spain, 24 October 2024, (Summary Text)

2. ADDING KNACK MANOEUVRE AND LIFESTYLE RECOMMENDATIONS TO PELVIC FLOOR MUSCLE TRAINING FOR POST-PROSTATECTOMY URINARY INCONTINENCE: A RANDOMIZED CONTROLLED TRIAL

Gerlegiz E. N., Akbayrak T., Gursen C., Mangir N., Yazici S., Akdogan B., et al.

52nd Annual Meeting of the International Continence Society (ICS 2022), Vienna, Austria, 7 - 10 September 2022, vol.2, no.100354, pp.288-289, (Summary Text)

3. Stereotactic Body Radiotherapy in Prostate Cancer: A Single Center Experience

AKYOL H. F., HÜRMÜZ P., YÜCE SARI S., Doğan Elmalı A., YÜCE D., YAZICI M. S., et al.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 24 - 30 April 2019, vol.133, pp.828, (Full Text) Sustainable Development